avixis 0.025% solucion topica
quimica suiza s.a.c. - alfatradiol; - solucion topica - por mililitro 5.00 ml - otros productos dermatológicos
avixis solución tópica 0,025% (alfatradiol)
galderma chile laboratorios ltda. - alfatradiol - sin formulas
avixis 0.025% solucion topica
quimica suiza s.a.c. - solucion topica - ; alfatradiol 25.000000 mg;
avixis solución capilar
gramon bago - solución capilar - alfatradiol 0,25 mg/ml solución capilar
avixis 0.025% solucion topica
quimica suiza s.a.c. - solucion topica
avixis 0.025% solución tópica
galderma international - solución tópica - 0.025%
plavix
sanofi winthrop industrie - klopidogreelin vetysulfaatti - stroke; peripheral vascular diseases; atrial fibrillation; myocardial infarction; acute coronary syndrome - antitromboottiset aineet - secondary prevention of atherothrombotic eventsclopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease;adult patients suffering from acute coronary syndrome:non-st-segment-elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa);st-segment-elevation acute myocardial infarction, in combination with asa in patients undergoing percutaneous coronary intervention (including patients undergoing a stent replacement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. in patients with moderate to high-risk transient ischemic attack (tia) or minor ischemic stroke (is)clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. ehkäisy aterotromboottisten ja tromboembolisten tapahtumien eteisen fibrillationin aikuisten eteisvärinäpotilailla, joilla on vähintään yksi verisuonitapahtumiin kuten tapahtumia, eivät sovellu hoito vitamiini-k-antagonistit ja joilla on vähäinen verenvuodon riski, klopidogreeli on tarkoitettu yhdistelmänä asa: n ehkäisyyn aterotromboottisten ja tromboembolisten tapahtumien, kuten aivoinfarktin.
coplavix 75mg+100mg tablets film-coated
sanofi winthrop industrie - clopidogrel, acetylsalicylic acid - tablets film-coated - 75mg+100mg
coplavix tablets film-coated
sanofi winthrop industrie - clopidogrel, acetylsalicylic acid - tablets film-coated - 75mg+ 100mg
ofloxavis 3 mg/ml colirio en solución
pharma stulln gmbh - ofloxacino - colirio en soluciÓn - 3 mg/ml - ofloxacino 3 mg - ofloxacino